School of Medicine
Showing 301-362 of 362 Results
-
Shih-Po Su
Postdoctoral Scholar, Ophthalmology
BioDr. Shih-Po Su is a Postdoctoral Research Fellow in the Department of Ophthalmology at Stanford University. He earned his Ph.D. in Biomedical Engineering from National Yang Ming Chiao Tung University (NYCU), Taiwan, in 2024. His doctoral research focused on the development of advanced optical imaging systems, including a three-dimensional near-infrared fluorescence and photoacoustic vascular imaging platform for preclinical applications.
Dr. Su has over a decade of experience in biomedical imaging, integrating optical system design, image analysis, and in vivo disease modeling. His research interests center on the interface of optical engineering and translational medicine, particularly in retinal ganglion cell (RGC) imaging and neuroprotective strategies for glaucoma. At Stanford, he is extending his expertise to short-wave infrared (SWIR/NIR-II) imaging and in vivo retinal functional imaging to establish sensitive biomarkers for neurodegeneration.
His recent work has advanced optical imaging and NIR-II contrast agents, including the co-development of polymer-dot probes for three-dimensional tumor and bone imaging (Chemical Science, 2022; Advanced Healthcare Materials, 2021) and an ultrabright polymer-dot platform for rotational stereo imaging (Advanced Healthcare Materials, 2024). He also designed integrated small-animal imaging systems combining bioluminescence tomography and ultrasound, as well as rotational stereo NIR-II fluorescence imaging (Optics Express, 2024; Journal of Biomedical Optics, 2023; Biosensors, 2022).
Dr. Su has received multiple international recognitions, including the Taiwan Science and Technology Hub@Stanford Postdoctoral Fellowship (2024), First Prize in the NYCU Annual Thesis Competition (2023), the Future Tech Award (MOST, 2022), and the MOST Pilot Scholarship Program (2019). His long-term goal is to develop regenerative medicine–based imaging and therapeutic platforms to address unmet clinical needs in neurodegenerative diseases and vision restoration. -
Yang Sun, MD, PhD
Professor of Ophthalmology
Current Research and Scholarly InterestsWe are interested in the role of inositol phosphatases in eye development and disease, using both animal models and human disease tissue. We are a translational laboratory seeking to understand the basic function of proteins as well as developing therapeutic strategies for clinical trials.
-
Christopher N. Ta, MD
Professor of Ophthalmology
BioChristopher N. Ta, MD specializes in the diagnosis and medical treatment of cornea diseases. His areas of expertise are in the treatment of ocular infections, inflammation, and ocular surface diseases. He has conducted numerous clinical trials toward the prevention and treatment of ocular infections. Dr. Ta also has extensive clinical experience in the treatment of ocular graft-versus host disease following hematopoietic stem cell transplantation.
-
Geoffrey Craig Tabin, MD
Fairweather Foundation Professor
BioDr. Geoff Tabin is Co-Founder and Chairman of the Himalayan Cataract Project and a Professor of Ophthalmology and Global Medicine at Stanford University. He has published more than 45 peer-reviewed articles, two books and a dozen book chapters related to his work in ophthalmology and the developing world.
Dr. Tabin is the fourth person in the world to reach the tallest peak on each of the seven continents. His passion for mountain climbing directed him to his professional career in eye care. After summiting Mt. Everest, on one of his expeditions, he came across a Dutch team performing cataract surgery on a woman who had been needlessly blind for three years. It was then he understood his life calling.
Tabin graduated from Yale University and then earned an MA in Philosophy at Oxford University on a Marshall Scholarship. From there, he took his interest in moral philosophy and health care delivery to Harvard Medical School where he earned his MD in 1985. After completing an ophthalmology residency at Brown University and a fellowship in corneal surgery in Melbourne, Australia, Dr. Tabin returned to Nepal to work with Dr. Sanduk Ruit.
Tabin and Nepalese eye surgeon Dr. Sanduk Ruit established the Himalayan Cataract Project in 1995 – with a vow to work to eliminate all preventable and treatable blindness from the Himalayan region in their lifetime, a goal, in Tabin’s words, “more audacious than setting out to make the first assent of the East Face of Mount Everest.” Dr. Ruit, whom the Associated Press heralded as the “god of sight” to the world’s poor, and Tabin have proven that hospital quality standards can be applied in impoverished areas devoid of electricity and clean water. Their successful approach to restoring sight and dogged perseverance has made possible what 20 years ago seemed impossible.
The Himalayan Cataract Project has since expanded beyond the Himalayas to encompass Sub-Saharan Africa as well. Dr.Tabin spends a considerable part of the year working abroad throughout the Himalayas and Sub-Saharan Africa. At Stanford his practice focus encompasses surgery and treatment of diseases of the anterior and external eye including cataract and corneal surgery. -
Imran Thobani
Postdoctoral Scholar, Ophthalmology
BioDr. Imran Thobani is a postdoctoral scholar in Ophthalmology co-advised by Dan Yamins and Andreas Tolias as part of the Enigma project. He is interested in building large-scale predictive models of the brain that he thinks will be useful for both scientific insights and downstream biomedical applications. He did his PhD at Stanford, where he was trained in both philosophy of neuroscience and computational neuroscience, applying this training to develop better methods for comparing artificial neural network models to the brain.
-
Daniel SW Ting
Adjunct Clinical Associate Professor, Ophthalmology
BioAssoc Prof Daniel Ting is a senior consultant vitreo-retinal surgeon working in the Singapore National Eye Center (SNEC), an Associate Professor with Duke-NUS Medical School and an Adjunct Clinical Associate Professor and an Innovation Mentor at Stanford University. He is also the Director of Singapore Health Service (SingHealth) AI Office, SNEC Chief Data and Digital Officer, and the Head of AI and Digital Innovation in Singapore Eye Research Institute (SERI). In 2017, Dr Ting was US-ASEAN Fulbright Scholar visiting the Johns Hopkins University Fulbright Scholar to share his expertise in AI and big data in medicine. In addition to that, his research focus span across not only on the technical aspect on machine learning, deep learning, large language models, explainable AI, privacy preserving technologies, but also safe, responsible and ethical clinical AI applications. He is also involved in several international consensus reporting guidelines such as STARD-AI, QUADAS-AI and DECIDE-AI.
To date, Daniel has published >250 publications on peer reviewed, book chapters, educational articles and conference abstracts. Of those, 45 were published in high impact journals (IF >10) such as JAMA, NEJM, Lancet, Nature Medicine, Nature Biomedical Engineering, Lancet Digital Health, Progress in Retinal and Eye Research, Diabetes Care, Nature Digital Medicine, Ophthalmology and etc. As of Aug 2024 (Google Scholar), his current H index: 61, i-10 index: 172 with total citations of >20,000. Dr Ting has received a total of 100M research grants, in which 20 M as a principal investigator, and 80M as co-investigators on AI and digital innovation related projects in health.
Dr Ting serves in several leadership positions at the different AI and eye societies, including the American Academy of Ophthalmology AI and Retina Ophthalmology Technology Assessment committees, and he also chairs the AI and Digital Innovation Standing Committee for the Asia-Pacific Academy of Ophthalmology and Asia-Pacific Vitreo-Retinal Society. He also serves in numerous advisory and editorial boards in the top-tiered digital and medical journals, including Lancet Digital Health, Frontiers in Medicine, Frontiers in Digital Health and Asia-Pacific Journal of Ophthalmology; Section Editor in British Journal of Ophthalmology and Editorial Board Member in Ophthalmology, Ophthalmology Retina, Ophthalmology Science, British Journal of Ophthalmology, Asia-Pacific Journal of Ophthalmology and Retina.
For the accomplishment, Dr Ting was recognized by many top-tiered international AI and ophthalmology societies in winning many prestigious scientific awards, including Tatler Asia Gen T Award (2021), Singapore National Clinician Scientist Award (2021), Asia-Pacific Academy Ophthalmology (APAO) Nakajima Award (2021), Asia-Pacific Vitreo-Retinal Society (APVRS) Ian Constable Award (2021), MICCAI OMIA Prestigious Achievement Award (2020), ARVO Bert Glaser Award for Innovative Research in Retina (2020), USA Macula Society Evangelos Gragoudas Award (2019), APAO Young Ophthalmologist’s Award (2018) and APTOS Young Innovator Award (2017).
In 2022, 2023 and 2024, he is included in the World’s Top 100 Ophthalmology Power list by the Ophthalmologists; and the World’s Top 2% Scientists by the Stanford University world ranking. In 2021, 2022 and 2023, he was consistently ranked top 3 in the deep learning domain over the past decades (2010 – 2023) by the ExpertScape. In 2024, he won the Singapore National Academy of Medicine Young Scientist Award, and also ranked the Top 100 AI Thought Leaders Worldwide with Fei Fei Li, Yan LeCun, Jensen Huang and many others by H20.ai. -
Andreas Tolias
Professor of Ophthalmology
BioAndreas Tolias is a faculty member at Stanford University, where he co-leads the Enigma Project. His research lies at the interface of neuroscience and AI, combining large-scale neuroscience experiments with machine learning to uncover the principles of natural intelligence. By focusing on perceptual inference and decision-making, his lab integrates systems and computational neuroscience with AI to decipher the network-level principles of intelligence. Dr. Tolias’s work aims to reverse-engineer these principles to create AI systems that are smarter, more robust, trustworthy, and efficient, while providing a powerful platform to test brain algorithms under complex natural tasks. He earned his B.A. and M.A. in Natural Sciences from the University of Cambridge, a Ph.D. in Systems and Computational Neuroscience from MIT, and completed postdoctoral training in Neuroscience and Machine Learning at the Max Planck Institute for Biological Cybernetics in Tübingen.
-
Sirin Triwutpipatkul
Affiliate, Ophthalmology Research/Clinical Trials
BioSirin Triwutpipatkul, MD is a board-certified ophthalmologist and fellowship-trained cornea and refractive specialist. She completed her ophthalmology residency and cornea fellowship at the Department of Ophthalmology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand. She also serves in Thailand's Ministry of Justice healthcare system, participating in nationwide collaborative research.
Her clinical interests include corneal disease, corneal transplantation, ocular surface disease, infectious keratitis, dry eye disease, and refractive surgery. Her research focuses on randomized clinical trials, international collaborations, and the application of artificial intelligence in corneal and refractive diseases.
Dr.Sirin is currently a Clinical and Research fellow at the Byers Eye Institute at Stanford University, where she is involved in clinical and international research in cornea and external diseases.
Outside of medicine, she enjoys exploring new places, traveling, cycling, and is always on the hunt for a great local coffee shop :) -
Janice Marie Turi
Web and Communications Specialist, Ophthalmology Operations
Current Role at StanfordSr. Manager, Web and Communications
Ophthalmology Operations -
Gabriel Velez, MD, PhD
Resident in Ophthalmology
Postdoc Res Affiliate, Ophthalmology Research/Clinical TrialsCurrent Role at StanfordResident Physician
-
Karen Wai, MD
Clinical Assistant Professor, Ophthalmology
BioDr. Wai is a board-certified ophthalmologist and fellowship-trained vitreoretinal surgeon with Stanford Health Care Byers Eye Institute. She is also a clinical assistant professor of ophthalmology in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Wai is a retina specialist who diagnoses and treats retinal and macular diseases, including age-related macular degeneration, diabetic retinopathy, retinal vascular occlusions (blockages), and retinal tears/detachments. The retina is a tissue layer in the back of the eye. It converts light into signals that the brain then interprets as images. The macula is the part of the retina responsible for central (straight ahead) vision. Diseases of the retina and macula can cause low vision and vision loss.
Dr. Wai’s research interests include working with data from electronic health record databases to improve patient outcomes. She has researched morbidity and mortality (illness and death) rates in patients with retinal vein occlusions and retinal artery occlusions. A retinal vein occlusion is a blocked vein to the retina that can cause vision loss. A retinal artery occlusion is when an artery to the retina is blocked, which is also sometimes referred to as eye stroke. Dr. Wai has also examined the effects of systemic medications on the retina. She has won several ophthalmology awards, including the Heed Fellowship and Harvard Medical School’s Excellence in Clinical Instruction Resident Award.
Dr. Wai has published in more than 40 peer-reviewed journals, including Ophthalmology, American Journal of Ophthalmology, and JAMA Ophthalmology. She has presented research at meetings and conferences around the United States.
Dr. Wai is a member of the American Board of Ophthalmology. -
Grzegorz Walkiewicz
Postdoctoral Scholar, Ophthalmology
BioGrzegorz (Greg) Walkiewicz, PhD, is a neuroscientist with a strong background in retinal and neurodegenerative disease research. He completed his PhD at KU Leuven (Belgium), focusing on tau pathology and Alzheimer’s disease. His research explores the connection between brain and eye pathology, with particular interest in pTau, Aβ, and microglial activation. He has worked extensively with transgenic mouse models as well as human brain and retinal tissues. He recently joined Stanford University to investigate INPP5K-related mechanisms in retinal ganglion cell degeneration.
-
Brian A. Wandell
Isaac and Madeline Stein Family Professor and Professor, by courtesy, of Electrical Engineering, of Ophthalmology and of Education
Current Research and Scholarly InterestsModels and measures of the human visual system. The brain pathways essential for reading development. Diffusion tensor imaging, functional magnetic resonance imaging and computational modeling of visual perception and brain processes. Image systems simulations of optics and sensors and image processing. Data and computation management for reproducible research.
-
Sophia Y. Wang, MD, MS
Assistant Professor of Ophthalmology
Current Research and Scholarly InterestsI use and integrate a wide variety of data sources in my research, spanning both structured and unstructured forms, including national survey datasets, health insurance claims data, patient generated online text, surgical video, and electronic health records. I investigate outcomes of treatments for glaucoma and cataract, as well as other areas of ophthalmology. My focus is on developing artificial intelligence methods to predict ophthalmology outcomes, while ensuring fairness.
-
Sui Wang, PhD
Associate Professor of Ophthalmology
Current Research and Scholarly InterestsOur research focuses on unraveling the molecular mechanisms underlying retinal development and diseases. We employ genetic and genomic tools to explore how various retinal cell types, including neurons, glia, and the vasculature, respond to developmental cues and disease insults at the epigenomic and transcriptional levels. In addition, we investigate their interactions and collective contributions to maintain retinal integrity.
1. Investigating retinal development:
We utilize genetic tools and methods such as in vivo plasmid electroporation and CRISPR to dissect the roles of cis-regulatory elements and transcription factors in controlling retinal development.
2. Understanding diabetes-induced cell-type-specific responses in the retina:
Diabetes triggers a range of multicellular responses in the retina, such as vascular lesions, glial dysfunction, and neurodegeneration, all of which contribute to retinopathy. We delve into the detailed molecular mechanisms underlying these diabetes-induced cell-type-specific responses and the pathogenesis of diabetic retinopathy.
3. Developing molecular tools for labeling and manipulation of specific cell types in vivo:
Cis-regulatory elements, particularly enhancers, play pivotal roles in directing tissue- and cell-type-specific expression. Our interest lies in identifying enhancers that can drive cell type-specific expression in the retina and brain. We incorporate these enhancers into plasmid or AAV-based delivery systems, enabling precise labeling and manipulation of specific cell types in vivo. -
Wenmin Wang
Postdoctoral Scholar, Ophthalmology
Current Research and Scholarly InterestsI am particularly interested in identifying therapeutic strategies for various eye disorders and investigating the mechanisms by which defects in inositol phosphatases lead to the disruption of primary cilia function and eye diseases by using Omics.
-
Tsai-Chu Yeh, MD, MTM
Postdoctoral Scholar, Ophthalmology
BioDr. Tsai-Chu Yeh is a dedicated vitreoretinal surgeon and scientist. During residency, she was honored with the Best Resident Award, and her research has been featured in Medscape News and the American Academy of Ophthalmology, earning numerous awards from the Association for Research in Vision and Ophthalmology, American Society of Retina Specialists, Fuji Retina, and the Taiwan Retina and Ocular Inflammation Society.
Beyond advancing science, Dr. Yeh is deeply committed to inspiring the next generation by making translational medicine both accessible and impactful. She received the Best Teacher Award for five consecutive years and was promoted to assistant professor as one of the youngest scholars in her field.
Motivated by a passion to bridge science and medicine, she joined the Mahajan Lab at Stanford University as a postdoctoral scholar, where she developed expertise in molecular genetics, honed her passion for discovery, and embraced the lessons of resilience and perseverance. Her research focuses on identifying protein signatures and molecular mechanisms underlying vitreoretinal diseases, aiming to pave the way for targeted, vision-restoring therapies.
Outside the lab and clinic, Dr. Yeh is a true renaissance woman. She finds joy in reading, music and art, and cherishes time with her family and friends. She also enjoys traveling, tennis, and golf. Her vibrant spirit infuses everything she does—bringing energy, empathy, and excellence to her work as a clinician, scientist, and surgeon. -
Charles Yu MD
Assistant Professor of Ophthalmology
Current Research and Scholarly InterestsCorneal opacity is a leading cause of blindness. Cornea transplantation is at high risk of rejection when there is pre-existing vascularization of the cornea and in pediatric patients. Cornea transplant shortage remains a worldwide problem with millions on waitlists. Our laboratory is developing multiple strategies for treatment of corneal blindness. We are testing advanced materials and designs for keratoprostheses with the goal of reducing complications and easing surgical implantation. We are also developing intraocular electronic display prostheses for bypassing cornea opacity, a novel strategy that could allow for high quality vision without corneal clarity.
-
Yuyang Zeng
Postdoctoral Scholar, Ophthalmology
Current Research and Scholarly InterestsTransgenic therapy for glaucoma based on disease-responsive promoters/enhancers
